Clinical Trials Logo

Clinical Trial Summary

This project optimizes the TCM Symptoms and Symptoms Scale. A curative effect evaluation system of acupuncture in the treatment of acute ischemic stroke is formed to provide clinical evidence by the following indexes: neurological impairment, motor dysfunction, TCM Symptoms and Symptoms Scale, combined with the patients' head MRI, Plasma BDNF, MMP-9 and other biomarkers.


Clinical Trial Description

Based on the previous work, this project optimizes the TCM Symptoms and Symptoms Scale. Through the cohort study method, 194 patients with acute ischemic stroke were evaluated for neurological impairment, motor dysfunction, TCM Symptoms and Symptoms Scale, combined with the patients' head MRI. , Plasma BDNF, MMP-9 and other biomarkers, screen TCM syndromes related to stroke outcome indicators, and adopt targeted comprehensive acupuncture and moxibustion program intervention and follow-up to establish a stroke-specific intervention outcome prediction model with TCM characteristics. A curative effect evaluation system of acupuncture and moxibustion in the treatment of acute ischemic stroke is formed to provide clinical evidence. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04528472
Study type Interventional
Source Shanghai University of Traditional Chinese Medicine
Contact qinhui fu, doctor
Phone 008613795396770
Email ff777315@163.com
Status Not yet recruiting
Phase N/A
Start date October 1, 2020
Completion date October 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04667078 - REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts Phase 3